Literature DB >> 14555683

Hypoxia-mediated prolonged elevation of sympathetic nerve activity after periods of intermittent hypoxic apnea.

Michael J Cutler1, Nicolette Muenter Swift, David M Keller, Wendy L Wasmund, Michael L Smith.   

Abstract

Obstructive sleep apnea (OSA) is associated with transient elevation of muscle sympathetic nerve activity (MSNA) during apneic events, which often produces elevated daytime MSNA in OSA patients. Hypoxia is postulated to be the primary stimulus for elevated daytime MSNA in OSA patients. Therefore, we studied the effects of 20 min of intermittent voluntary hypoxic apneas on MSNA during 180 min of recovery. Also, we compared MSNA during recovery after either 20 min of intermittent voluntary hypoxic apneas, hypercapnic hypoxia, or isocapnic hypoxia. Consistent with our hypothesis, both total MSNA and MSNA burst frequency were elevated after 20 min of intermittent hypoxic apnea compared with baseline (P < 0.05). Both total MSNA and MSNA burst frequency remained elevated throughout the 180-min recovery period and were statistically different from time control subjects throughout this period (P < 0.05). Finally, MSNA during recovery from intermittent hypoxic apnea, hypercapnic hypoxia, and isocapnic hypoxia were not different (P = 0.50). Therefore, these data support the hypothesis that short-term exposure to intermittent hypoxic apnea results in sustained elevation of MSNA and that hypoxia is the primary mediator of this response.

Entities:  

Mesh:

Year:  2003        PMID: 14555683     DOI: 10.1152/japplphysiol.00506.2003

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  54 in total

1.  Chronic infusion of angiotensin receptor antagonists in the hypothalamic paraventricular nucleus prevents hypertension in a rat model of sleep apnea.

Authors:  Ana Quenia Gomes da Silva; Marco Antônio Peliky Fontes; Nancy Lapp Kanagy
Journal:  Brain Res       Date:  2010-10-30       Impact factor: 3.252

Review 2.  The sympathetic nervous system and catecholamines metabolism in obstructive sleep apnoea.

Authors:  Valeria Bisogni; Martino F Pengo; Giuseppe Maiolino; Gian Paolo Rossi
Journal:  J Thorac Dis       Date:  2016-02       Impact factor: 2.895

Review 3.  Obstructive sleep apnea: the new cardiovascular disease. Part I: Obstructive sleep apnea and the pathogenesis of vascular disease.

Authors:  Rami Khayat; Brian Patt; Don Hayes
Journal:  Heart Fail Rev       Date:  2008-09-20       Impact factor: 4.214

4.  Increased cardio-respiratory coupling evoked by slow deep breathing can persist in normal humans.

Authors:  Thomas E Dick; Joseph R Mims; Yee-Hsee Hsieh; Kendall F Morris; Erica A Wehrwein
Journal:  Respir Physiol Neurobiol       Date:  2014-09-28       Impact factor: 1.931

Review 5.  Apneic Sleep, Insufficient Sleep, and Hypertension.

Authors:  Meghna P Mansukhani; Naima Covassin; Virend K Somers
Journal:  Hypertension       Date:  2019-04       Impact factor: 10.190

Review 6.  Hypoxia-inducible factors and obstructive sleep apnea.

Authors:  Nanduri R Prabhakar; Ying-Jie Peng; Jayasri Nanduri
Journal:  J Clin Invest       Date:  2020-10-01       Impact factor: 14.808

Review 7.  Pathophysiology of sleep apnea.

Authors:  Jerome A Dempsey; Sigrid C Veasey; Barbara J Morgan; Christopher P O'Donnell
Journal:  Physiol Rev       Date:  2010-01       Impact factor: 37.312

Review 8.  Sympathoadrenal mechanisms in the pathogenesis of sleep apnea-related hypertension.

Authors:  Oded Friedman; Alexander G Logan
Journal:  Curr Hypertens Rep       Date:  2009-06       Impact factor: 5.369

Review 9.  Chemoreflexes, sleep apnea, and sympathetic dysregulation.

Authors:  Meghna P Mansukhani; Tomas Kara; Sean M Caples; Virend K Somers
Journal:  Curr Hypertens Rep       Date:  2014-09       Impact factor: 5.369

10.  Glucose intolerance and gestational diabetes risk in relation to sleep duration and snoring during pregnancy: a pilot study.

Authors:  Chunfang Qiu; Daniel Enquobahrie; Ihunnaya O Frederick; Dejene Abetew; Michelle A Williams
Journal:  BMC Womens Health       Date:  2010-05-14       Impact factor: 2.809

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.